Clinical trials in Legnano – page 126

2 907 clinical trials in Legnano, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in ItalyStudi-Clinici.it

Legnano at a glance

2 907

clinical trials

Research sites1

Quick filters

2 907 trials in Legnano

Open in trial search

Metabolic dysfunction-associated steatohepatitis+1

Not recruiting

Study of resmetirom (MGL-3196) in patients with Non-Alcoholic Steatohepatitis (NASH) to prevent liver damage and disease progression

Investigational

Study of resmetirom (MGL-3196) in patients with Non-Alcoholic Steatohepatitis (NASH) to prevent liver damage and disease progression

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Resmetirom
Sponsor:Madrigal Pharmaceuticals Inc.

Contact Research Centre

Dementia Alzheimer's type

Not recruiting

Study on the Effects of AR1001 (Mirodenafil Dihydrochloride) for Patients with Early Alzheimer's Disease

Investigational

Study on the Effects of AR1001 (Mirodenafil Dihydrochloride) for Patients with Early Alzheimer's Disease

Investigational

Italy

Participants:18–64 years · 65+ years
Sponsor:Aribio Co. Ltd.

Contact Research Centre

Crohn's disease

Not recruiting

Study on the Long-Term Safety and Efficacy of Oral Ozanimod for Patients with Moderate to Severe Crohn's Disease

InvestigationalNo placebo

Study on the Long-Term Safety and Efficacy of Oral Ozanimod for Patients with Moderate to Severe Crohn's Disease

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Ozanimod
Sponsor:Celgene International II S.a.r.l.

Contact Research Centre

Psoriatic arthropathy

Not recruiting

Study on Guselkumab for Treating Psoriatic Arthritis in Patients New to Biologic Therapy

Investigational

Study on Guselkumab for Treating Psoriatic Arthritis in Patients New to Biologic Therapy

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Guselkumab
Sponsor:Janssen Cilag International

Contact Research Centre

Dementia Alzheimer's type

Not recruiting

Study on the Effects of GV1001 for Patients with Mild to Moderate Alzheimer's Disease

Investigational

Study on the Effects of GV1001 for Patients with Mild to Moderate Alzheimer's Disease

Investigational

Italy

Participants:18–64 years · 65+ years
Sponsor:Gemvax & Kael Co. Ltd.

Contact Research Centre

Colitis ulcerative+1

Not recruiting

Study on the Effects of TEV-48574 for Adults with Moderate to Severe Ulcerative Colitis or Crohn's Disease

Investigational

Study on the Effects of TEV-48574 for Adults with Moderate to Severe Ulcerative Colitis or Crohn's Disease

Investigational

Italy

Participants:18–64 years · 65+ years
Sponsor:Teva Branded Pharmaceutical Products R&D LLC

Contact Research Centre

Metabolic dysfunction-associated steatohepatitis+1

Not recruiting

Study on the Effects of Semaglutide in Patients with Non-Alcoholic Steatohepatitis (NASH) and Fibrosis Stages 2 or 3

Registered drug

Study on the Effects of Semaglutide in Patients with Non-Alcoholic Steatohepatitis (NASH) and Fibrosis Stages 2 or 3

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Semaglutide
Sponsor:Novo Nordisk A/S

Contact Research Centre

Relapsing multiple sclerosis

Not recruiting

Study of LY3541860 and Meglumine Gadoterate for Adults with Relapsing Multiple Sclerosis

Registered drug

Study of LY3541860 and Meglumine Gadoterate for Adults with Relapsing Multiple Sclerosis

Registered drug

Italy

Participants:18–64 years
Substances:LY3541860
Sponsor:Eli Lilly & Co.

Contact Research Centre

Chronic kidney disease+1

Not recruiting

Study on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure

Registered drug

Study on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Baxdrostat
Sponsor:Astrazeneca AB

Contact Research Centre

Colitis ulcerative

Not recruiting

Study on the Effects of Guselkumab and Golimumab for Patients with Moderate to Severe Ulcerative Colitis

Investigational

Study on the Effects of Guselkumab and Golimumab for Patients with Moderate to Severe Ulcerative Colitis

Investigational

Italy

Participants:18–64 years
Substances:Golimumab
Sponsor:Janssen Cilag International

Contact Research Centre

Study on Bendamustine, Rituximab, and Acalabrutinib for Patients with Untreated Mantle Cell Lymphoma

Not recruiting

Registered drug

Study on Bendamustine, Rituximab, and Acalabrutinib for Patients with Untreated Mantle Cell Lymphoma

Registered drug

Italy

Participants:65+ years
Substances:Acalabrutinib
Sponsor:Acerta Pharma B.V.

Contact Research Centre

Psoriatic arthropathy

Not recruiting

Study on Tildrakizumab for Patients with Active Psoriatic Arthritis Who Have Previously Used Anti-TNF Therapy

Registered drug

Study on Tildrakizumab for Patients with Active Psoriatic Arthritis Who Have Previously Used Anti-TNF Therapy

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Tildrakizumab
Sponsor:Sun Pharmaceutical Industries Limited

Contact Research Centre

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Legnano

What the registry says about research in the country

01 Hematologic Oncology

Extensive research focusing on Multiple Myeloma treatments, including innovative therapies for relapsed and refractory cases. Studies evaluating new drug combinations and treatment approaches for better patient outcomes.

Melflufen therapy for elderly patients
Elranatamab monotherapy trials
Novel combination treatments for RRMM

Multiple ongoing trials testing various therapeutic combinations to improve survival rates.

02 Solid Tumors

Groundbreaking studies in lung cancer and breast cancer treatment, investigating novel immunotherapy combinations and targeted therapies.

Advanced NSCLC immunotherapy trials
HER2-positive breast cancer treatments
Colorectal cancer targeted therapies

Focus on personalized treatment approaches and biomarker-driven therapies.

03 Chronic Conditions

Innovative research in chronic kidney disease and HIV management, exploring new treatment strategies and medication combinations.

Non-diabetic kidney disease treatments
HIV antiretroviral therapy optimization
Ulcerative colitis interventions

Studies aimed at improving long-term patient outcomes and quality of life.

Back to Italy All countries